Semaglutide dosing typically starts at 0.25 mg and titrates upward to 2.4 mg over several weeks, allowing the body to adapt and minimize nausea and gastrointestinal side effects
The safety profile at weekly dosing is well-established and favorable for most patients
Male C57BL/6J mice (SPF grade) at 8 weeks in age were obtained from the Shanghai Slac Laboratory Animal Co
For faster and visible whitening, injections are the preferred choice
has received consulting honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daichii-Sankyo, Eli Lilly, esanum, Gilead, Ipsen, Novartis, Novo Nordisk, Sandoz and Sanofi, and has received research grants from AstraZeneca, Eli Lilly and Novo Nordisk